Cerebral Oxygenation and Metabolism After Hypoxia-Ischemia
Overview
Authors
Affiliations
Perinatal hypoxia-ischemia (HI) is still a significant contributor to mortality and adverse neurodevelopmental outcomes in term and preterm infants. HI brain injury evolves over hours to days, and involves complex interactions between the endogenous protective and pathological processes. Understanding the timing of evolution of injury is vital to guide treatment. Post-HI recovery is associated with a typical neurophysiological profile, with stereotypic changes in cerebral perfusion and oxygenation. After the initial recovery, there is a delayed, prolonged reduction in cerebral perfusion related to metabolic suppression, followed by secondary deterioration with hyperperfusion and increased cerebral oxygenation, associated with altered neurovascular coupling and impaired cerebral autoregulation. These changes in cerebral perfusion are associated with the stages of evolution of injury and injury severity. Further, iatrogenic factors can also affect cerebral oxygenation during the early period of deranged metabolism, and improving clinical management may improve neuroprotection. We will review recent evidence that changes in cerebral oxygenation and metabolism after HI may be useful biomarkers of prognosis.
Cardiac biomarkers predict low right ventricle performance in neonatal encephalopathy.
Moore S, Lapointe A, Rampakakis E, Simoneau J, Elias P, Poccia A J Perinatol. 2025; .
PMID: 40089578 DOI: 10.1038/s41372-025-02262-9.
Dmytriv T, Duve K, Storey K, Lushchak V Front Physiol. 2024; 15:1443604.
PMID: 39161701 PMC: 11330875. DOI: 10.3389/fphys.2024.1443604.
Lear C, Lear B, Davidson J, King V, Maeda Y, McDouall A J Cereb Blood Flow Metab. 2024; 44(8):1376-1392.
PMID: 38415649 PMC: 11342719. DOI: 10.1177/0271678X241236014.
Advances in Therapies to Treat Neonatal Hypoxic-Ischemic Encephalopathy.
Ranjan A, Gulati A J Clin Med. 2023; 12(20).
PMID: 37892791 PMC: 10607511. DOI: 10.3390/jcm12206653.
Andelius T, Bogh N, Pedersen M, Omann C, Andersen M, Andersen H Front Pediatr. 2023; 11:1167396.
PMID: 37325341 PMC: 10264796. DOI: 10.3389/fped.2023.1167396.